22:23:29Canada

BioAtla, Inc. (BCAB)

OTC Markets

Key stats Fiscal year 2025

Income statement

Net income
-59,607,000
Operating income
-59,305,000
Earnings per share
-1.01
R&D expense
43,573,000

Growth and profitability

Return on assets
-431.06

Balance sheet

Total assets
13,828,000
Total liabilities
50,017,000
Shareholders' equity
-36,189,000
Cash and equivalents
7,118,000
Current ratio
0.37

Cash flow and ratios

Operating cash flow
-48,204,000

Shareholder returns

Shares outstanding
32,315,301
Revenue and net income
Debt, free cash flow and cash
Earnings per share

Company information

Headquarters
San Diego, CA
Exchange
OTC Markets
Fiscal year end
12-31
Industry (SEC)
Biological Products, (no Diagnostic Substances)

Fiscal year end: · Source: SEC EDGAR

BioAtla, Inc. trades on OTC Markets under the ticker symbol BCAB. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis